MedTrace Logo

Gut Hormones and Roux en Y Gastric Bypass

NCT01945840 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 190

Last updated 2021-04-20

No results posted yet for this study

Summary

The purpose of this study is to assess whether the changes in gut hormones seen following Roux en Y Gastric Bypass surgery are responsible for some of the beneficial effects seen post-operatively.

Conditions

Interventions

PROCEDURE

Roux en Y Gastric Bypass Surgery

OTHER

Gut hormone infusion

OTHER

Placebo infusion

OTHER

Very low calorie diet

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Stephen R Bloom, FRS FRCP MD · Imperial College London

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2028-10-31
Completion
2028-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01945840 on ClinicalTrials.gov